Clozapine is associated with secondary antibody deficiency / Mark Ponsford en The British Journal of Psychiatry, Año 2019 - Vol. 214 - No.2 (Febrero)

Público ISBD [artículo]  inThe British Journal of Psychiatry > Año 2019 - Vol. 214 - No.2 (Febrero) . - pp. 83-89 Título : Clozapine is associated with secondary antibody deficiency Tipo de documento: texto impreso Autores: Mark Ponsford, Autor ; Daniel Castle, Autor ; Tayyeb Tahir, Autor Fecha de publicación: 2019 Artículo en la página: pp. 83-89 Idioma : Inglés (eng) Palabras clave: Clozapina, Esquizofrenia, Neumonía, vacunación, Deficiencia de anticuerpos secundarios Resumen: Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia. Clozapine is also associated with increased risk of pneumonia although the mechanism is poorly understood. Link: ./index.php?lvl=notice_display&id=20526 [artículo] Clozapine is associated with secondary antibody deficiency [texto impreso] / Mark Ponsford, Autor ; Daniel Castle, Autor ; Tayyeb Tahir, Autor . - 2019 . - pp. 83-89. Idioma : Inglés (eng) in The British Journal of Psychiatry > Año 2019 - Vol. 214 - No.2 (Febrero) . - pp. 83-89 Palabras clave: Clozapina, Esquizofrenia, Neumonía, vacunación, Deficiencia de anticuerpos secundarios Resumen: Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia. Clozapine is also associated with increased risk of pneumonia although the mechanism is poorly understood. Link: ./index.php?lvl=notice_display&id=20526

---

1 (1 - 1 / 1)